ZIM
PRAH

Zacks Investment Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Zacks Investment Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,961
Closed -$910K – 607
2020
Q1 		$910K Sell
10,961
-7,394
-40% -$721K 0.02% 311
2019
Q4 		$2.04M Buy
18,355
+334
+2% +$34.4K 0.04% 261
2019
Q3 		$1.79M Sell
18,021
-893
-5% -$88.7K 0.04% 286
2019
Q2 		$1.88M Sell
18,914
-598
-3% -$57.1K 0.04% 279
2019
Q1 		$2.15M Sell
19,512
-318
-2% -$33.2K 0.05% 247
2018
Q4 		$1.82M Sell
19,830
-4,429
-18% -$448K 0.04% 242
2018
Q3 		$2.67M Buy
24,259
+195
+0.8% +$20.3K 0.06% 227
2018
Q2 		$2.25M Sell
24,064
-34,183
-59% -$2.94M 0.05% 251
2018
Q1 		$4.83M Sell
58,247
-2,256
-4% -$200K 0.11% 151
2017
Q4 		$5.51M Buy
60,503
+11,272
+23% +$938K 0.12% 137
2017
Q3 		$3.75M Buy
49,231
+346
+0.7% +$26.1K 0.09% 161
2017
Q2 		$3.67M Buy
48,885
+614
+1% +$42.6K 0.09% 162
2017
Q1 		$3.15M Buy
48,271
+1,924
+4% +$113K 0.08% 175
2016
Q4 		$2.56M Buy
46,347
+32,909
+245% +$1.81M 0.07% 183
2016
Q3 		$759K Sell
13,438
-7,163
-35% -$351K 0.02% 387
2016
Q2 		$860K Buy
20,601
+6,857
+50% +$316K 0.03% 356
2016
Q1 		$588K Buy
13,744
+3,790
+38% +$160K 0.02% 425
2015
Q4 		$451K Buy
+9,954
New +$418K 0.01% 434

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Zacks Investment Management's PRAH Position: Q2 2020 in Review

Zacks Investment Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 10,961 shares — an estimated $910K sold.

Zacks Investment Management first reported a position in PRAH in Q4 2015 and held it in 18 quarters. The position peaked at $5.51M in Q4 2017. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

  • Zacks Investment Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
  • Zacks Investment Management sold 10,961 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $910K.
  • Zacks Investment Management first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 18 quarters.
  • Zacks Investment Management's PRA Health Sciences, Inc. position peaked at $5.51M in Q4 2017.
  • 293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.